News, Publications & Insights

Explore the latest news and publications, innovation milestones, and drug-device insights from PARI and our pharmaceutical partners leveraging eFlow® Technology.

PARI Partner Project News

Partner Project News

Enterprise Therapeutics achieves primary efficacy outcome in Phase 2 clinical trial for cystic fibrosis with novel inhaled ENaC blocker ETD001

PARI Publication

PARI Publication

A Novel Human Factors Approach for a New Platform-Based, Breath-Triggered Nebuliser

Published

December 11, 2024

Categories

eFlow Integrated
PARI Publications

eFlow Integrated – Aerosol Performance of a Novel Breath-Triggered Nebulizer

Published

June 26, 2024

Category

Partner News

Savara Announces Molgramostim Nebulizer Solution (Molgramostim) Achieved Statistical Significance for Primary Endpoint and Multiple Secondary Endpoints in IMPALA-2, a Pivotal Phase 3 Clinical Trial in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

Published

June 12, 2024

Categories

eFlow Integrated
PARI Publications

Optimising inhalation adherence and technique: The power of digital technology

Published

April 30, 2024

Category

Partner News

Renovion Announces Positive Top-Line Results from Phase 2 CLIMB Study of ARINA-1 (RVN-301) in Patients with Non-Cystic Fibrosis Bronchiectasis

Published

April 9, 2024

Categories

eFlow Integrated
PARI Publications

Deep breaths, deep dives: The new eFlow Integrated nebuliser

Contact us

eFlow-partneringpari.com

Two smiling men in a blue circle. The central man wears glasses and a light blue shirt. The man on the left has a beard and a blue patterned shirt.

PARI Business Development Team